The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-15
DOI
10.1038/s41598-018-26278-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling
- (2016) Tsung-Hua Hsieh et al. Scientific Reports
- Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents
- (2014) Ranjan Preet et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients
- (2014) Julia Richter et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the β-catenin nuclear transport pathway in cancer
- (2014) Cara Jamieson et al. SEMINARS IN CANCER BIOLOGY
- Inhibition of topoisomerase II α activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analogues
- (2012) Jintapat Nateewattana et al. INVESTIGATIONAL NEW DRUGS
- A Phytoestrogen Diarylheptanoid Mediates Estrogen Receptor/Akt/Glycogen Synthase Kinase 3β Protein-dependent Activation of the Wnt/β-Catenin Signaling Pathway
- (2012) Kanit Bhukhai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Electrophilic natural products and their biological targets
- (2012) Malte Gersch et al. NATURAL PRODUCT REPORTS
- The -Catenin Destruction Complex
- (2012) J. L. Stamos et al. Cold Spring Harbor Perspectives in Biology
- New substituted C-19-andrographolide analogues with potent cytotoxic activities
- (2011) Uthaiwan Sirion et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer
- (2011) Jonathan Chee Woei Lim et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P‐glycoprotein
- (2011) Ling Ye et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Synthesis, cytotoxicity, and structure–activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent
- (2010) Bimolendu Das et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Chromosomal Instability Pathway in Colon Cancer
- (2010) Maria S. Pino et al. GASTROENTEROLOGY
- Balancing the efficacy and toxicity of chemotherapy in colorectal cancer
- (2010) Michael S. Braun et al. Therapeutic Advances in Medical Oncology
- Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis
- (2008) S R Jada et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More